Regenerative Biomaterials, Department of Dentistry, Radboudumc, Philips van Leydenlaan 25, Nijmegen, 6525EX, The Netherlands.
Leijten Laboratory, Department of BioEngineering Technologies, University of Twente, Drienerlolaan 5, Enschede, 7522NB, The Netherlands.
Small. 2024 Nov;20(46):e2403272. doi: 10.1002/smll.202403272. Epub 2024 Aug 1.
Osteoclasts, the bone resorbing cells of hematopoietic origin formed by macrophage fusion, are essential in bone health and disease. However, in vitro research on osteoclasts remains challenging due to heterogeneous cultures that only contain a few multinucleated osteoclasts. Indeed, a strategy to generate homogeneous populations of multinucleated osteoclasts in a scalable manner has remained elusive. Here, the investigation focuses on whether microencapsulation of human macrophages in microfluidically generated hollow, sacrificial tyramine-conjugated dextran (Dex-TA) microgels could facilitate macrophage precursor aggregation and formation of multinucleated osteoclasts. Therefore, human mononuclear cells are isolated from buffy coats and differentiated toward macrophages. Macrophages are encapsulated in microgels using flow focus microfluidics and outside-in enzymatic oxidative phenolic crosslinking, and differentiated toward osteoclasts. Morphology, viability, and osteoclast fusion of microencapsulated cells are assessed. Furthermore, microgels are degraded to allow cell sorting of released cells based on osteoclastic marker expression. The successful encapsulation and osteoclast formation of human macrophages in Dex-TA microgels are reported for the first time using high-throughput droplet microfluidics. Intriguingly, osteoclast formation within these 3D microenvironments occurs at a significantly higher level compared to the conventional 2D culture system. Furthermore, the feasibility of establishing a pure osteoclast culture from cell transfer and release from degradable microgels is demonstrated.
破骨细胞是由巨噬细胞融合形成的造血来源的骨吸收细胞,对骨骼健康和疾病至关重要。然而,由于异质培养物中仅包含少数多核破骨细胞,体外研究破骨细胞仍然具有挑战性。事实上,以可扩展的方式生成均质多核破骨细胞群体的策略仍然难以实现。在这里,研究集中在将人巨噬细胞微囊封在微流控生成的中空、牺牲型酪胺偶联的葡聚糖(Dex-TA)微凝胶中是否可以促进巨噬细胞前体聚集和多核破骨细胞的形成。因此,从血袋中分离人单核细胞并向巨噬细胞分化。使用流聚焦微流控技术和外向酶氧化酚交联将巨噬细胞封装在微凝胶中,并向破骨细胞分化。评估微囊化细胞的形态、活力和破骨细胞融合。此外,降解微凝胶以允许基于破骨细胞标志物表达对释放细胞进行细胞分选。首次使用高通量液滴微流控技术报告了人巨噬细胞在 Dex-TA 微凝胶中的成功微囊化和破骨细胞形成。有趣的是,与传统的 2D 培养系统相比,这些 3D 微环境中的破骨细胞形成水平显著提高。此外,还证明了从可降解微凝胶中转移和释放细胞建立纯破骨细胞培养的可行性。